After two weeks of MNs treatment, the vitiligo scores of the control group and the tacrolimus ointment-treated group were still higher than 3 points, while the scores of the mice treated with the HGDexMA/α-MSH/tofacitinib MNs had even dropped to about 1 point. This evidence concerns the gene STAMBP and vitiligo.